Objective: Previous studies have suggested that suicide rates are elevated among cancer patients relative to the general population. In this analysis, we comprehensively evaluated characteristics associated with higher suicide rates among patients with cancers of the digestive system. injury." Suicide rates were compared to age-, sex-, and race-adjusted rates in the general population.
| INTRODUCTION
Suicide is the 10th leading cause of death in the United States, accounting for over 40 000 deaths 1 in 2014. After a consistent decline in the late 1980s through the 1990s, US suicide rates increased steadily from 1999 through 2014, with increases observed among adolescents and both young and middle-aged adults. 2 Characteristics typically associated with higher suicide rates in the general population include older age, white race, and male sex. Chronic or debilitating physical illnesses, such as cancer, have also been included among the major risk factors for suicide. 3 Previous US-based studies have demonstrated that suicide rates in cancer patients are significantly higher than in the general population. In a study of US cancer patients diagnosed from 1973 to 2002 using data from the Surveillance, Epidemiology, and End Results (SEER) program, the age-, sex-, and race-adjusted suicide rate among cancer patients (31.4/100 000 person-years) was nearly twice that in the general US population (16.7/100 000 person-years). 4 More recently, Kam et al 5 conducted an in-depth analysis of suicide among patients diagnosed with head and neck cancer between 1973 and 2011, finding higher rates among those with hypopharyngeal and laryngeal cancers, sites linked to loss of function in speaking and swallowing ability. To our knowledge, such a comprehensive analysis has not been conducted among cancers of the digestive system, many of which also have poor prognoses and physical symptoms associated with reduced quality of life. Identifying cancer patient subgroups with higher suicide rates may help in directing mental health services and other forms of psychological support to those most in need.
The aim of this study was to investigate suicide rates among patients with cancers of the digestive system compared with the general population. We also examined whether suicide rates were higher in subgroups defined by anatomic cancer site, stage, time since diagnosis, and patient characteristics.
| MATERIALS AND METHODS

| Data source
We identified patients with cancers of the digestive system using data from the SEER program of the National Cancer Institute. The SEER program is a system of population-based cancer registries, which are located strategically throughout the country and cover approximately 28% of the total US population. 6 In addition to cancer incidence data, SEER also conducts active follow-up for patient vital status and reports survival and mortality data, including cause of death as ascertained from death certificates. For this study, we used the Public 
| Study population
We included all patients with digestive system tumors, as defined by the SEER site recode ICD-O-3/WHO 2008, who were diagnosed during 2000 to 2014. Cancer sites of the digestive system include the esophagus, stomach, small intestine, colon, rectum and rectosigmoid junction, anus, anal canal and anorectum, liver and intrahepatic bile duct, gallbladder, other biliary, pancreas, retroperitoneum, peritoneum, omentum and mesentery, and other digestive organs. 9 Our study cohort was restricted to those with a first primary tumor with malignant behavior and known patient age.
Cases identified through death certificate or autopsy only were excluded. We classified patient deaths as suicides if the cause of death, as defined by the SEER cause of death recode, 10 was listed as "suicide and self-inflicted injury."
| Statistical analysis
Suicide rates among patients with cancers of the digestive system were calculated as the number of observed suicides per 100 000 per- 
| RESULTS
A total of 856 292 patients with cancers of the digestive system were identified ( Table 1 ). The most common cancer sites among patients in this cohort were colon (37%), rectum and rectosigmoid junction (16%), and pancreas (14%). Most patients were white (78%), male (54%), married (53%), and diagnosed at ages 60 and older (69%) with localized or regional stage cancers (64%). Overall, a total of 881 suicides were observed over 2 688 837 person-years of follow-up (mean = 3.14 years) ( In analyses stratified by sex, the suicide rate among men was higher than that in the general population for all cancer sites, with the highest SMRs among those with pancreatic or esophageal cancer (Table 2) . Suicide rates were substantially lower among female patients than among males. Although the highest suicide rate was observed among women with esophageal cancer, the SMRs were only significantly elevated for women with colon cancer (SMR = 1.43; 95% CI, 1.06-1.88) and other digestive cancers (SMR = 2.32; 95% CI, 1.40-3.62).
In site-specific analyses, SMRs increased with age at diagnosis, with the highest among those aged 70+ years, for all sites except colon cancer and stomach cancer ( Figure 1 (Table 3) . Standardized mortality ratios remained elevated for all cancer sites between 2 months and 5 years after diagnosis but were not significantly different from the general population at five or more years postdiagnosis.
In multivariable-adjusted analyses within the cancer patient cohort, characteristics associated with higher suicide rates included a diagnosis of esophageal, pancreatic, or stomach cancer, as well as male sex, white race, and older age at diagnosis. Being unmarried, having regional or distant stage disease, and not having surgery were also associated with higher suicide rates (Table S1) . Other includes small intestine, anus, anal canal and anorectum, gallbladder, other biliary, retroperitoneum, peritoneum, omentum, and mesentery, and other digestive organs.
symptoms or treatment side effects. [20] [21] [22] [23] The reasons for this apparent decrease are not clear, given only slight improvements in pancreatic cancer prognosis since the early 2000s. 27 It is possible that developments in symptom management and palliative care, or increasing availability and use of these approaches, 28, 29 may be at least partially attributable.
The issues surrounding suicide in terminally ill patients are complex and have been the subject of considerable moral and ethical debate. For many cancers of the digestive system, including esophageal, liver, and pancreatic, 5-year relative survival is less than 50%, even among those with localized disease. [30] [31] [32] Such poor prognoses may be accompanied by feelings of depression and hopelessness, which may precipitate suicidality in cancer patients. 14 Routine screening for depression and suicidal ideation in cancer patients has been proposed, and several tools are available to aide in the early identification of those experiencing these symptoms. 14, 33 While there remains limited evidence of the effectiveness of screening initiatives to reduce suicide rates in oncology settings, the involvement of psychiatrists and other mental health professionals may be a critical component of cancer care for high-risk patient subgroups, particularly within the first couple months of diagnosis when suicide risk is highest.
| Study limitations
Our study has several limitations, including those inherent to the use of registry data sources such as SEER. Information on depressive symptoms, comorbidities, physical functioning, and substance abuse is not available in SEER but would help to further refine the identification of patients at high risk for suicide. Cause of death ascertained from death certificates may also be subject to misclassification, and therefore, suicides rates in our analyses may be underestimated.
However, relatively high sensitivity and specificity have been reported
for the coding of suicide on death certificates with a physician review panel as the gold standard for cause of death determination. 34 Furthermore, any underestimation of suicides rates is likely similar between cancer patients and the general population, making it less likely that our SMR estimates are substantially biased. We also could not account for the impact of cancer recurrences on suicide rates, as recurrence information is not captured by SEER.
| Clinical implications
Our findings suggest that rates of suicide are significantly elevated among patients with cancers of the digestive system compared with the general population, with particularly high rates for those recently diagnosed with esophageal and pancreatic cancers. Although suicide is a relatively rare occurrence even among patients with advanced
cancer, health care providers should be aware of high-risk subgroups and should use appropriate screening tools and referrals to mental health services when indicated.
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